Skip to content

Clinical trials

Phase 3 Hyperlipidemias trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 3 Country / region: Israel Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20071
20132
20141
20151
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Pfizer2
Takeda2
Bayer1
Merck Sharp & Dohme LLC1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias13
Hypercholesterolemia5
Cardiovascular Diseases4
Dyslipidemias4
Myocardial Infarction3
Stroke3
Homozygous Familial Hypercholesterolemia2
Hypertension2
Aortic Valve Stenosis1
Atherosclerosis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.